Researchers from several U.S. institutions are collaborating "to develop and test an implantable device able to sense signs of the kind of inflammation associated with cancer," reports CBS N… Read More

Market Overview The Electrochemical Sensor Market was valued at USD 6.19 billion in 2023 and is expected to reach USD 11.83 billion by 2033, at a CAGR of 11.4% over the for… Read More

The North America atomic layer deposition market is expected to register a CAGR of 5% over the forecast period . The atomic layer deposition (ALD) is a technique of producing a high-quality… Read More

More than $9 million has been awarded to three Monash University researchers in the 2022 ARC Australian Laureate Fellowships. The Fellowships, announced earlier this week, were awarded to Pr… Read More

U.S. scientists have achieved the previously unthinkable task of remotely controlling the brains of living beings. The beings, in this case, are genetically engineered fruit flies and the… Read More

A video has been viewed thousands of times on Facebook that claims a biosensor made by US digital health company Profusa is set to be injected into people through COVID-19 vaccines… Read More

The wearables revolution is well underway in healthcare, and patients are already benefiting from portable therapies and monitors that are improving their lives. But many challenges still r… Read More

Global Nano Therapy Market – Overview Nano Therapy technique, performed with the help of nanoparticles is used for the treatment of various diseases including chronic diseases such… Read More

Operation Coronavirus is Working Hand-in-Hand with the Nanotech Agenda by Makia FreemanThe Freedom Articles The nanotech agenda – involving the placement of tiny sensors, devices a… Read More

The report of the global Nano therapy market by Type (Nanomaterial and Biological Device, Nano Electronic Biosensor, Molecular Nanotechnology, Implantable Cardioverter-Defibrillators), Appli… Read More

IMAGE: Robert Magnussonview more  Credit: UT Arlington A research team from The University of Texas at Arlington is working with the Army Research Laboratory to develop na… Read More

The commercialization scale of biosensors market has been commendable since the development of the first oxygen biosensor by Lel and Clark back in 1962. The remarkable penetration of this in… Read More

For critical drugs like those used in chemotherapy, getting the dose right for every patient is a challenge: everyone’s physiology is different and too much or too little can be… Read More

Today’s third of four installments covering the Rocky Mountain Life Science Investor Conference focuses on the medical device presenting companies. In addition, here are some links to… Read More